NuSirt Biopharma, Inc. has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents.

The company has protected the discovery and application of this broad based technology platform through an extensive IP portfolio that includes twenty-two issued or allowed to date with corresponding patents pending globally. NuSirt has successfully conducted multiple clinical studies that have validated its discovery and demonstrated the value of its intellectual property.

Learn More

Request more information.


NuSirt News

Randomized Controlled Trial of a Leucine-Metformin-Sildenafil Combination (NS-0200) on Weight and Metabolic Parameters.

View Article

Video –  NuSirt: Targeting Metabolism to attack obesity, cardiometabolic risk and aging

See All News

Contact

3835 Cleghorn Avenue, Suite 200
Nashville, TN 37215